| Literature DB >> 20858234 |
Abstract
BACKGROUND: Many patients who receive steroid pulse therapy go home the same day or the day after steroid administration. Nursing instructions are important for improving patient knowledge related to their diseases and treatments, but the short hospital stay often prevents complete education and guidance regarding the given therapy. The purpose of this study was to investigate the need for nursing instruction in patients receiving steroid pulse therapy for the treatment of autoimmune diseases and the effect of instruction on patient knowledge of their disease and treatment.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20858234 PMCID: PMC2954988 DOI: 10.1186/1471-2474-11-217
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Figure 1Flow chart of the study design.
Demographics data and characteristics of study subjects (N = 63)
| Variable | Number (%) |
|---|---|
| Age (years) | |
| ≤30 | 26 (41.2) |
| 31-40 | 17 (27.0) |
| > 40 | 20 (31.8) |
| Gender | |
| Male | 14 (22.2) |
| Female | 49 (77.8) |
| Education level | |
| Below college | 32 (50.8) |
| College and above | 31 (49.2) |
| Body weight change (kg) | |
| < 2 | 49 (77.8) |
| ≥2 | 14 (22.2) |
| Drug dosage (mg)* | |
| ≤500 | 26 (41.3) |
| > 501 | 37 (58.7) |
| Frequency of treatment | |
| 1 | 29 (46.0) |
| ≥2 | 34 (54.0) |
| Diagnosis† | |
| SLE group | 43 (68.2) |
| Non-SLE group | 20 (31.8) |
| Hospital stay (days) | |
| ≤5 | 20 (31.8) |
| 6-10 | 20 (31.8) |
| ≥11 | 23 (36.4) |
*Patients receive methylprednisolone treatment.
†Among the 63 subjects, there were 43 diagnosed with systemic lupus erythematosus (SLE group). Among those patients, 4 were complicated with RA and 6 were complicated with sicca syndrome. The other 20 patients had systemic sclerosis (non-SLE group).
Relationship between patient characteristics and level of symptom distress before intervention associated with pulse therapy (N = 63)
| Cardio-pulmonary | Endocrine | Musculoskeletal | Gastrointestinal | Nervous | Optic | Integument | Immune | Reproductive | Overall | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Variable | ||||||||||||||||||||
| Age (years) | ||||||||||||||||||||
| ≤30 | 2.24 ± 0.85 | 1.84 ± 0.65 | 2.35 ± 1.23 | 2.11 ± 0.84 | 1.93 ± 1.03 | 1.37 ± 0.49 | 2.65 ± 1.27 | 1.74 ± 0.80 | 1.44 ± 0.53 | 1.94 ± 0.60 | ||||||||||
| 31-40 | 1.95 ± 0.76 | 1.86 ± 0.74 | 2.38 ± 1.30 | 2.05 ± 1.08 | 1.89 ± 0.83 | 1.48 ± 0.97 | 2.06 ± 1.12 | 1.52 ± 0.76 | 1.47 ± 0.75 | 1.84 ± 0.71 | ||||||||||
| > 40 | 2.10 ± 0.76 | 0.518 | 1.77 ± 0.66 | 0.912 | 2.34 ± 1.21 | 0.996 | 1.97 ± 0.83 | 0.878 | 2.17 ± 0.85 | 0.591 | 2.52 ± 1.14 | < 0.001* | 2.10 ± 1.04 | 0.172 | 1.71 ± 0.63 | 0.609 | 1.24 ± 0.51 | 0.418 | 1.97 ± 0.55 | 0.790 |
| Gender | ||||||||||||||||||||
| Male | 2.13 ± 0.61 | 2.10 ± 0.63 | 3.00 ± 1.37 | 2.39 ± 0.89 | 2.41 ± 0.91 | 2.29 ± 1.59 | 2.27 ± 1.30 | 1.87 ± 0.73 | 1.09 ± 0.18 | 2.15 ± 0.64 | ||||||||||
| Female | 2.11 ± 0.84 | 0.953 | 1.74 ± 0.66 | 0.076 | 2.17 ± 1.17 | 0.023* | 1.95 ± 0.88 | 0.109 | 1.88 ± 0.89 | 0.053 | 1.62 ± 0.72 | 0.027* | 2.33 ± 1.15 | 0.878 | 1.61 ± 0.73 | 0.248 | 1.47 ± 0.64 | 0.031* | 1.86 ± 0.59 | 0.122 |
| Education level | ||||||||||||||||||||
| Below college | 2.14 ± 0.86 | 1.83 ± 0.67 | 2.34 ± 1.26 | 1.97 ± 0.81 | 1.96 ± 0.93 | 1.79 ± 0.91 | 2.39 ± 1.28 | 1.76 ± 0.78 | 1.38 ± 0.49 | 1.93 ± 0.63 | ||||||||||
| College and above | 2.09 ± 0.73 | 0.792 | 1.81 ± 0.67 | 0.914 | 2.37 ± 1.21 | 0.923 | 2.13 ± 0.98 | 0.481 | 2.04 ± 0.92 | 0.725 | 1.74 ± 01.11 | 0.820 | 2.24 ± 1.08 | 0.620 | 1.57 ± 0.68 | 0.313 | 1.39 ± 0.68 | 0.902 | 1.92 ± 0.59 | 0.927 |
| Body weight change (kg) | ||||||||||||||||||||
| < 2 | 1.98 ± 0.73 | 1.71 ± 0.65 | 2.11 ± 1.09 | 1.89 ± 0.79 | 1.88 ± 0.85 | 1.62 ± 0.85 | 2.24 ± 1.17 | 1.64 ± 0.74 | 1.39 ± 0.61 | 1.82 ± 0.57 | ||||||||||
| ≥2 | 2.60 ± 0.86 | 0.008* | 2.21 ± 0.59 | 0.011* | 3.19 ± 1.32 | 0.003* | 2.61 ± 1.02 | 0.006* | 2.41 ± 1.05 | 0.053 | 2.26 ± 1.36 | 0.037* | 2.26 ± 1.21 | 0.386 | 1.77 ± 0.73 | 0.562 | 1.36 ± 0.52 | 0.848 | 2.30 ± 0.61 | 0.007* |
| Drug dosage (mg) | ||||||||||||||||||||
| ≤500 | 2.09 ± 0.86 | 1.85 ± 0.66 | 2.18 ± 1.09 | 2.04 ± 1.01 | 1.84 ± 0.89 | 1.48 ± 0.60 | 2.55 ± 1.25 | 1.64 ± 0.74 | 1.39 ± 0.57 | 1.88 ± 0.62 | ||||||||||
| > 501 | 2.14 ± 0.75 | 0.835 | 1.81 ± 0.68 | 0.813 | 2.48 ± 1.32 | 0.344 | 2.05 ± 0.82 | 0.940 | 2.11 ± 0.93 | 0.255 | 1.96 ± 1.18 | 0.063 | 2.15 ± 1.11 | 0.192 | 1.69 ± 0.74 | 0.779 | 1.38 ± 0.61 | 0.928 | 1.96 ± 0.61 | 0.627 |
| Frequency of treatment | ||||||||||||||||||||
| 1 | 1.97 ± 0.75 | 1.72 ± 0.61 | 2.43 ± 1.33 | 1.89 ± 1.01 | 2.10 ± 0.97 | 1.58 ± 0.92 | 2.08 ± 1.56 | 1.56 ± 0.66 | 1.28 ± 0.48 | 1.83 ± 0.59 | ||||||||||
| ≥2 | 2.24 ± 0.82 | 0.182 | 1.91 ± 0.71 | 0.251 | 2.29 ± 1.14 | 0.660 | 2.18 ± 0.77 | 0.197 | 1.91 ± 0.88 | 0.431 | 1.92 ± 1.07 | 0.178 | 2.51 ± 1.17 | 0.151 | 1.76 ± 0.79 | 0.271 | 1.48 ± 0.67 | 0.181 | 2.01 ± 0.62 | 0.246 |
| Diagnosis | ||||||||||||||||||||
| SLE group | 1.95 ± 0.74 | 1.75 ± 0.60 | 2.87 ± 1.49 | 2.12 ± 0.99 | 2.08 ± 0.93 | 1.66 ± 1.86 | 2.04 ± 1.28 | 1.59 ± 0.697 | 1.16 ± 0.30 | 1.89 ± 0.60 | ||||||||||
| Non-SLE group | 2.19 ± 0.81 | 0.256 | 1.86 ± 0.70 | 0.561 | 2.11 ± 1.01 | 0.021* | 2.01 ± 0.85 | 0.665 | 1.96 ± 0.92 | 0.628 | 1.81 ± 0.98 | 0.576 | 2.44 ± 1.12 | 0.210 | 1.71 ± 0.756 | 0.561 | 1.49 ± 0.66 | 0.039* | 1.94 ± 0.62 | 0.790 |
| Hospital stay (days) | ||||||||||||||||||||
| ≤5 | 1.82 ± 0.61 | 1.56 ± 0.55 | 1.93 ± 1.15 | 1.67 ± 0.49 | 1.53 ± 0.57 | 1.46 ± 0.69 | 1.98 ± 1.06 | 1.65 ± 00.70 | 1.24 ± 00.42 | 1.63 ± 0.42 | ||||||||||
| 6-10 | 2.21 ± 0.81 | 1.93 ± 0.59 | 2.60 ± 1.24 | 2.17 ± 1.06 | 2.22 ± 0.91 | 1.97 ± 1.16 | 2.44 ± 1.03 | 1.62 ± 00.73 | 1.44 ± 0.69 | 2.04 ± 0.598 | ||||||||||
| ≥11 | 2.30 ± 0.87 | 0.119 | 1.96 ± 0.77 | 0.101 | 2.50 ± 1.23 | 0.170 | 2.27 ± 0.94 | 0.066 | 2.21 ± 1.05 | 0.020* | 1.85 ± 1.07 | 0.245 | 2.49 ± 1.37 | 0.308 | 1.73 ± 00.79 | 0.880 | 1.46 ± 0.63 | 0.422 | 2.07 ± 0.68 | 0.034* |
*P < 0.05.
Data were expressed as mean ± SD
P value derived from ANOVA test, α = 0.05.
Relationship between patient characteristics and need of nursing instruction at four time points during pulse therapy (N = 63)
| Before | Immediately After | One Week After | Two Weeks After | |||||
|---|---|---|---|---|---|---|---|---|
| Variable | ||||||||
| Overalla | 1.95 ± 0.99 | - | 1.82 ± 0.93 | 0.030* | 0.40 ± 0.16 | < 0.001* | 1.34 ± 0.44 | < 0.001* |
| Age (years) | ||||||||
| ≤30 | 1.95 ± 0.98 | 1.71 ± 0.96 | 0.38 ± 0.14 | 1.30 ± 0.37 | ||||
| 31-40 | 1.68 ± 0.99 | 1.58 ± 0.77 | 0.39 ± 0.18 | 1.31 ± 0.48 | ||||
| > 40 | 2.18 ± 0.99 | 0.324 | 2.16 ± 0.95 | 0.123 | 0.44 ± 0.16 | 0.504 | 1.43 ± 0.51 | 0.597 |
| Gender | ||||||||
| Male | 2.37 ± 1.14 | 2.00 ± 0.79 | 0.45 ± 0.17 | 1.38 ± 0.42 | ||||
| Female | 1.83 ± 0.93 | 0.075 | 1.77 ± 0.96 | 0.401 | 0.39 ± 0.15 | 0.193 | 1.33 ± 0.45 | 0.700 |
| Education level | ||||||||
| Below college | 2.07 ± 1.18 | 2.01 ± 1.12 | 0.41 ± 0.17 | 1.37 ± .48 | ||||
| College and above | 1.83 ± 0.76 | 0.340 | 1.62 ± 0.64 | 0.100 | 0.40 ± 0.15 | 0.843 | 1.31 ± 0.41 | 0.569 |
| Body weight change (kg) | ||||||||
| < 2 | 1.69 ± 0.69 | 1.61 ± 0.73 | 0.37 ± 0.14 | 1.28 ± 0.38 | ||||
| ≥2 | 2.84 ± 1.36 | < 0.001* | 2.54 ± 01.19 | 0.001* | 0.50 ± 0.18 | 0.009 | 1.57 ± 0.59 | 0.031* |
| Drug dosage (mg) | ||||||||
| ≤500 | 1.75 ± 0.79 | 1.65 ± 0.74 | 0.38 ± 0.15 | 1.32 ± 0.41 | ||||
| > 501 | 2.09 ± 1.10 | 0.175 | 1.94 ± 1.03 | 0.227 | 0.41 ± 0.17 | 0.455 | 1.36 ± 0.47 | 0.737 |
| Frequency of treatment | ||||||||
| 1 | 1.72 ± 0.63 | 1.57 ± 0.59 | 0.39 ± 0.14 | 1.31 ± 0.39 | ||||
| ≥2 | 2.15 ± 1.19 | 0.088 | 2.03 ± 1.11 | 0.048* | 0.41 ± 0.17 | 0.735 | 1.36 ± 0.49 | 0.657 |
| Diagnosis | ||||||||
| SLE group | 2.14 ± 1.16 | 2.03 ± 1.09 | 0.41 ± 0.16 | 1.29 ± 0.37 | ||||
| Non-SLE group | 1.87 ± 0.91 | 0.310 | 1.72 ± 0.84 | 0.230 | 0.40 ± 0.16 | 0.727 | 1.36 ± 0.48 | 0.547 |
| Hospital stay (days) | ||||||||
| ≤5 | 1.55 ± 0.92 | 1.55 ± 0.99 | 0.34 ± 0.13 | 1.23 ± 0.45 | ||||
| 6-10 | 2.09 ± 0.91 | 1.83 ± 0.68 | 0.38 ± 0.13 | 1.24 ± 0.27 | ||||
| ≥11 | 2.19 ± 1.05 | 0.080 | 2.04 ± 1.03 | 0.230 | 0.47 ± 0.18 | 0.019* | 1.52 ± 0.51 | 0.043* |
Need for nursing instruction was evaluated using a 5-point Likert scale, with 5 indicating the greatest need.
*P < 0.05.
Data were expressed as mean ± SD
a P value derived from paired t-test for overall, and ANOVA test among multiple categories of other specific variables, α = 0.05.
Mixed model analysis of correlation between patient characteristics and the need for nursing instruction
| Effect | β | SE | |
|---|---|---|---|
| Intercept | 0.980 | 0.3537 | 0.007* |
| Body weight change (kg) | |||
| < 2 | . | . | |
| ≥2 | 0.460 | 0.1617 | 0.005* |
| Frequency of treatment | |||
| 1 | . | . | |
| ≥2 | 0.327 | 0.137 | 0.019* |
| Hospital stay (days) | |||
| ≤5 | . | . | |
| 6-10 | 0.079 | 0.1594 | 0.620 |
| ≥11 | 0.103 | 0.1703 | 0.548 |
| Symptom distress | 0.777 | 0.1079 | < 0.001* |
| Knowledge level | -0.012 | 0.0039 | 0.003* |
*P < 0.05.
Knowledge level before and after nursing instruction (N = 63)
| Variable | Knowledge Score | Paired | |
|---|---|---|---|
| Before nursing instruction | 70.06 | -4.60 | < 0.001* |
| After nursing instruction | 80.00 |
*Knowledge level of subjects after nursing instruction was significantly higher than before nursing instruction (P < 0.001).